KWF
Lead4Life PPP 2026 – Enabling Technologies for Clinical Introduction of Lead-212
12:00 noon; full proposal phase. Matchmaking phase precedes full proposal. Institutes not yet registered must submit registration request at least 6 weeks before closing date.
Last verified:
Details
| Funder | KWF |
| Budget | €0.5M–€2M per project (total pillar budget €2.0M) |
| Deadline | 22 September 2026 |
| Duration | Up to 4 years |
| Consortium | Required — public-private partnership consortium; Consortium Agreement between all participants is mandatory |
| Application | 2-stage: matchmaking phase → full proposal (deadline 22 Sep 2026) |
| Frequency | One-off |
| Eligible countries | NL |
Eligibility & scope
Health~Holland PPP call for 1–6 projects on enabling technologies for safe clinical use of Pb-212 radiopharmaceuticals (chelators, radiobiology, dosimetry, QC, hospital infrastructure). Requires active private-party co-investment; private party must not be an undertaking in difficulty (RVO declaration). Projects embedded in Lead4Life governance and national TRT network. Proposals submitted via KWF GMS using mandatory PPP-2026-L4L forms.
Related on Grantsby
- KWF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
More from KWF
KWF Proof of Concept 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATKWF Proof of Concept (PoC) Programme – Call 2026-PoC-2
Deadline: 2 Jun 2026Up to €150,000 incl. VATProof Of Concept 2026-2
Deadline: 2 Jun 2026INTER-LOCAL: International Call for Better Local Treatment of Rare/Hard-to-Treat Cancers
Deadline: 18 Jun 2026International consortium funding (5 European charities)INTER-LOCAL: International Clinical Trials in Local Treatment for Rare and Hard-to-Treat Cancers
Deadline: 18 Jun 2026Up to €3M
Does this grant match your research?
Sign up free to get a personalised match score and weekly alerts for grants like this.
Get started free